Los puntos clave no están disponibles para este artículo en este momento.
This study provides class IV level of evidence that 24 months of PRET or mFC may improve attention and working memory in nondemented patients with mild-to-moderate Parkinson's disease.
David et al. (Mon,) studied this question.